Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast ...

Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter- --Company to host conference call and webcast ...

Ketamine, a decades-old anesthetic and fast-acting treatment for severe depression, may also offer some people rapid relief ...

Are you thinking about pursuing a master’s degree at business school? Learn how to select the program that is the right fit for you ...

Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...

Virgin Australia has appointed Andrew Cleary to the role of chief customer officer and CEO Velocity, bringing all customer ...

The Tarrant County Sheriff’s Office wants additional state dollars to support its collaboration with federal immigration ...

Public-private insurance programmes must evolve beyond their traditional role as post-disaster payout mechanisms, according ...

Report shows millions of Virginians live in an area “without sufficient staffing to maintain the critical functions” of emergency management ...

Q4 2025 product revenue of €240 million and FY 2025 product revenue of €684 millionQ4 2025 operating profit of €10 million and cash flow from operating activities of €73 millionTransCon- CNP under FDA ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company ...